Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linagliptin dose-finding study in children and adolescents with type 2 diabetes
2009-017004-91Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of linagliptin in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by Boehringer Ingelheim. Primary endpoint: Change from baseline in HbA1c. Started Jan 2011; status: completed.
02
Drugs
linagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2009-017004-91.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017004-91.